Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion
Danièle Klett, Claire Cahoreau, Mélanie Villeret et al. · 2010
Read Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion by Danièle Klett, Claire Cahoreau, Mélanie Villeret et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009507.txt.
Description
Daniele Klett and colleagues tested hormone like chemicals on a cell enzyme in PLOS ONE in 2010. The enzyme, called PDI, helps new proteins fold in the cell's inner workshop. It also binds hormones such as estrogen and thyroid hormone. Some man made compounds can mimic hormones and disrupt the body. The team asked whether such compounds also impair PDI.
Using a lab assay for one of PDI's tasks, they measured how the compounds changed its activity. Several of them did alter the enzyme's work. That finding flags a new route by which hormone mimics could harm cells. The harm would come not just from false signals, but from faulty protein folding.
Catalog record
| CREATOR | Danièle Klett, Claire Cahoreau, Mélanie Villeret et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009507